KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with a poor overall prognosis. However, curative resection during the early stages of the disease can greatly improve survival rates, highlighting the importance of early screening and detection. Studies of noncoding RNAs, primarily microRN...
Guardado en:
Autores principales: | Shuang-Ni Yu, Yi-Hui Ma, Wu-Gan Zhao, Xiang-Lan Jin, Hai-Yan Yang, Ping-Ping Liu, Jie Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/616dfffbe4b94d05bbfda3011c760d44 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
por: YuHai Hu, et al.
Publicado: (2021) -
Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma
por: Huai-Qiang Ju, et al.
Publicado: (2017) -
Advances in Pancreatic Ductal Adenocarcinoma Treatment
por: Eric M. Anderson, et al.
Publicado: (2021) -
Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma
por: Imteyaz Ahmad Khan, et al.
Publicado: (2021) -
Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
por: Shiwei Guo, et al.
Publicado: (2021)